Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 658 results for "erbitux"

Merck KGaA Names Pharmaceutical Head Oschmann Deputy CEO

Merck KGaA, the German maker of Erbitux cancer medicine, promoted Stefan Oschmann to deputy chief executive officer and appointed Belen Garijo as its first female board member. Oschmann, currently head of the pharmaceutical unit, and Garijo, now ... BusinessWeek, 1 month ago
Seeking Alpha

Putting the Patient First: Merck Serono to Present Data That Embodies the ESMO 2014 Theme of

ESMO 2014 Abstract #: Physician biomarker survey: 1080O_PR; Erbitux: CRYSTAL: 541P; LASCCHN: 993PD; DIRECT: 996P; Pipeline: pimasertib: 443O; c-Met: 1333TiP, 450PD, 744TiP, 745TiP; further pipeline: 772P, 507PD, 1235P ...
 Newswit.com1 month ago Merck KGaA : Putting the Patient First: Merck Serono to Present Data That Embodies the ESMO 2014 Theme of Precision Medicine in Cancer Care  4 Traders1 month ago Merck on Track with Pharma Strategy  Bionity.com1 month ago Merck KGaA : on Track with Pharma Strategy; Pipeline Progress Announced  4 Traders1 month ago
[x]  
Securities Technology Monitor

Advaxis Appoints David J. Mauro, M.D., Ph.D., as Chief Medical Officer

Former Executive Director, Section Head Oncology Clinical Development at Merck & Co., Inc. and Director of Erbitux Medical Strategy at Bristol-Myers Squibb to Oversee Advaxis's Clinical Programs PRINCETON, N.J., Oct. 20, 2014 (GLOBE NEWSWIRE) -- ...
 Securities Technology Monitor1 week ago Advaxis, Inc. Appoints David J. Mauro, M.D., Ph.D., As Chief Medical Officer  FierceBiotech6 days ago Advaxis, Inc. Appoints As Chief Medical Officer  BioSpace1 week ago Advaxis : Appoints David J. Mauro, M.D., Ph.D., as Chief Medical Officer  4 Traders1 week ago
[x]  

Eli Lilly : Trademark Application for "ERBITUX CETUXIMAB" Filed

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a trademark application has been made for "ERBITUX CETUXIMAB" by Robert E. Lee , Jr., representing ...
 4 Traders1 week ago Genovis : Researchers Submit Patent Application, "Endoglycosidase from Streptococcus Pyogenes and Methods Using It", for Approval  4 Traders1 week ago

Rosetta Genomics Partners with Admera Health for the Commercialization of Current and Future Sequencing-Based Oncology Tests

Rosetta Genomics Ltd. ( NASDAQ:ROSG ), a leading developer and provider of microRNA-based molecular diagnostics and therapeutics, announces a collaboration with Admera Health, a spin-off from the clinical services unit of ...
 Fat Pitch Financials19 hours ago ROSETTA GENOMICS USA : Partners with Admera Health for the Commercialization of Current and Future Sequencing-Based Oncology Tests  4 Traders18 hours ago
[x]  

Monoclonal Antibody Market: Global and China Market Analysis, Industry Size, Share, Growth, Trends and Forecsat Report 2014-2019 Available Online by MarketResearchReports

Market Research Reports.Biz include new market research report "Global And China Monoclonal Antibody Industry Report 2014-2019" to its huge collection of research reports. Albany, NY -- (ReleaseWire) -- 10/29/2014 -- Despite world-wide economic ...
 Digital Journal1 day ago Research and Markets Adds Report: Global and China Monoclonal Antibody Industry Report,-2019  Individual.com2 days ago Global and China Monoclonal Antibody Industry Report 2014-2019  PharmiWeb1 day ago Research and Markets: Global and China Monoclonal Antibody Industry Report 2014-2019  BioMedReports6 days ago
[x]  

Alchemia Shares Plummet On Failed Colorectal Cancer Trial

Alchemia Announces Phase 3 Trial Results For HA-Irinotecan In Metastatic Colorectal Cancer BRISBANE, AUSTRALIA--(Marketwired - Oct 26, 2014) - Alchemia Limited ( ASX : ACL ) Summary: Phase III trial does not reach primary endpoint of ...
 BioSpace3 days ago Alchemia (ACL.AX) Shares Plummet On Failed Colorectal Cancer Trial 10/27/2014  ClinicSpace1 day ago
Virtual Strategy Magazine

China Independent Clinical Laboratory Market Size 2014, Industry Analysis, Shares, Growth, Trends and Forecast 2017: MarketResearchReports.Biz

PRWeb The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there was around RMB3.5 billion, up as much as ...
 CEOWorld Magazine3 days ago
[x]  
Pharmafocus

How Do You Solve a Problem like England's Cancer Drugs Fund?

By Leela Barham. The Cancer Drugs Fund (CDF) is a particular English approach to deal with rejections by the National Institute for Health and Care Excellence (NICE) for new cancer medicines. It's now worth £280million a year — still a drop in ...
 Pharmaceutical Executive3 days ago Cancer Drugs Fund in England: Plugging a Gap in Cancer Care  Medscape3 weeks ago AZ shares climb on positive cancer drug news  Pharmafocus1 month ago
4 Traders

Alchemia Announces Phase III Trial Results for HA-Irinotecan in Metastatic Colorectal Cancer

BRISBANE, AUSTRALIA -- (Marketwired) -- 10/26/14 -- Alchemia Limited (ASX: ACL) Summary: Drug discovery and development company Alchemia Limited (ASX: ACL), today announced that its pivotal Phase III trial of HA-Irinotecan in the treatment of ...
 BusinessWeek4 days ago Alchemia : Announces Phase III Trial Results for HA-Irinotecan in Metastatic Colorectal Cancer  4 Traders4 days ago Alchemia Announces Database Lock of Its HA-Irinotecan Pivotal Phase III Trial in Metastatic Colorectal Cancer  Scottrade3 weeks ago Alchemia : Announces Database Lock of Its HA-Irinotecan Pivotal Phase III Trial in Metastatic Colorectal Cancer  4 Traders3 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less